Cambridge, MA, United States of America

Kirsten Gruis

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Precigen, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirsten Gruis. Retrieved from https://idiyas.com/inventor/kirsten-gruis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kirsten Gruis: Innovator in Genetic Research

Introduction

Kirsten Gruis is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of genetic research, particularly in the treatment of Friedreich's Ataxia. With a total of 2 patents, her work is paving the way for advancements in medical science.

Latest Patents

Kirsten's latest patents include innovative frataxin expression constructs. These inventions provide polynucleotides, vectors, and viruses that express frataxin, along with methods for treating Friedreich's Ataxia. Her research is crucial for developing effective therapies for this debilitating condition.

Career Highlights

Kirsten is currently employed at Precigen, Inc., where she continues to push the boundaries of genetic research. Her work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

Kirsten collaborates with notable colleagues, including Stephen Ezra Schauer and Darby Thomas. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Kirsten Gruis is a dedicated inventor whose work in genetic research is making a significant impact. Her contributions to the treatment of Friedreich's Ataxia highlight her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…